Metopimazine

2-Nitropropane.

3 4'-DINITROCHALCONE

Matrix: Methanol-P&T

c-Met inhibitor 1 is an inhibitor of the c-Met receptor signaling pathway useful for the treatment of cancer including gastric, glioblastoma, and pancreatic cancer .IC50 value:Target: c-MetMore details please refer to Patent WO 2012015677 A1.

c-Met/RON Dual Kinase Inhibitor is an inhibitor of both Met and Ron.

Coelentarazine h

Coelentarazine h

Coelenterazine

Coelenterazine

Coelenterazine

A potent, orally bioavailable, ATP-competitive small-molecule dual inhibitor of c-MET (IC₅₀ = 8 nM) and ALK (IC₅₀ = 20 nM) receptor tyrosine kinases shows antitumor efficacy in multiple tumor models implanted in athymic mice

A potent, orally bioavailable, ATP-competitive small-molecule dual inhibitor of c-MET (IC₅₀ = 8 nM) and ALK (IC₅₀ = 20 nM) receptor tyrosine kinases shows antitumor efficacy in multiple tumor models implanted in athymic mice